Beijing Institute of Pharmacology and Toxicology, Beijing, China.
Synapse. 2013 Nov;67(11):779-85. doi: 10.1002/syn.21682. Epub 2013 Jul 4.
Thienorphine is a new nonselective partial agonist of opioid receptors, which is currently under a Phase II clinical trial in China as a new treatment for opioid dependence. In this study, we compared the effect of thienorphine with morphine on long-term potentiation (LTP) in the lateral perforant path (LPP)-granule cell synapse of the rat dentate gyrus (DG). Furthermore, the effect of thienorphine on the synaptic structure of the CA1 hippocampal region and the expression of synaptophysin was investigated. Results indicated interesting differences between thienorphine and morphine on the modulation of hippocampal synaptic plasticity. Chronic thienorphine treatment facilitated LTP in the LPP-DG cell synapses more than chronic morphine treatment. Morphometric measurement and analysis showed that chronic thienorphine administration decreased the length of the active zone and reduced the thickness of CA1 postsynaptic densities compared with the saline group (control), but were elevated compared with the morphine group. Furthermore, the expression of hippocampal synaptophysin was increased with chronic thienorphine administration but reduced with chronic morphine treatment. Taken together, our study clearly demonstrates that chronic thienorphine treatment enhances LTP, modulates hippocampal synaptic structure, and increases the expression of hippocampal synaptophysin. Therefore, further study is warranted to investigate thienorphine as a new treatment for opioid dependence.
蒂芬诺啡是一种新型非选择性阿片受体部分激动剂,目前正在中国进行 II 期临床试验,作为治疗阿片类药物依赖的新方法。在这项研究中,我们比较了蒂芬诺啡与吗啡对大鼠齿状回(DG)外侧穿通路径(LPP)-颗粒细胞突触长时程增强(LTP)的影响。此外,还研究了蒂芬诺啡对 CA1 海马区突触结构和突触小体蛋白表达的影响。结果表明,蒂芬诺啡和吗啡在调节海马突触可塑性方面存在有趣的差异。慢性蒂芬诺啡处理比慢性吗啡处理更能促进 LPP-DG 细胞突触的 LTP。形态测量和分析表明,与生理盐水组(对照组)相比,慢性蒂芬诺啡给药减少了活性区的长度,并降低了 CA1 突触后密度的厚度,但与吗啡组相比则升高。此外,慢性蒂芬诺啡给药增加了海马突触小体蛋白的表达,但慢性吗啡处理则降低了其表达。综上所述,本研究清楚地表明,慢性蒂芬诺啡处理增强了 LTP,调节了海马突触结构,并增加了海马突触小体蛋白的表达。因此,有必要进一步研究蒂芬诺啡作为治疗阿片类药物依赖的新方法。